These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. In Vitro and Molecular Surveillance for Antimalarial Drug Resistance in Plasmodium falciparum Parasites in Western Kenya Reveals Sustained Artemisinin Sensitivity and Increased Chloroquine Sensitivity. Lucchi NW; Komino F; Okoth SA; Goldman I; Onyona P; Wiegand RE; Juma E; Shi YP; Barnwell JW; Udhayakumar V; Kariuki S Antimicrob Agents Chemother; 2015 Dec; 59(12):7540-7. PubMed ID: 26392510 [TBL] [Abstract][Full Text] [Related]
6. Increased prevalence of the Plasmodium falciparum Pfmdr1 86N genotype among field isolates from Franceville, Gabon after replacement of chloroquine by artemether-lumefantrine and artesunate-mefloquine. Lekana-Douki JB; Dinzouna Boutamba SD; Zatra R; Zang Edou SE; Ekomy H; Bisvigou U; Toure-Ndouo FS Infect Genet Evol; 2011 Mar; 11(2):512-7. PubMed ID: 21251998 [TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine. Venkatesan M; Gadalla NB; Stepniewska K; Dahal P; Nsanzabana C; Moriera C; Price RN; Mårtensson A; Rosenthal PJ; Dorsey G; Sutherland CJ; Guérin P; Davis TME; Ménard D; Adam I; Ademowo G; Arze C; Baliraine FN; Berens-Riha N; Björkman A; Borrmann S; Checchi F; Desai M; Dhorda M; Djimdé AA; El-Sayed BB; Eshetu T; Eyase F; Falade C; Faucher JF; Fröberg G; Grivoyannis A; Hamour S; Houzé S; Johnson J; Kamugisha E; Kariuki S; Kiechel JR; Kironde F; Kofoed PE; LeBras J; Malmberg M; Mwai L; Ngasala B; Nosten F; Nsobya SL; Nzila A; Oguike M; Otienoburu SD; Ogutu B; Ouédraogo JB; Piola P; Rombo L; Schramm B; Somé AF; Thwing J; Ursing J; Wong RPM; Zeynudin A; Zongo I; Plowe CV; Sibley CH; Asaq Molecular Marker Study Group Am J Trop Med Hyg; 2014 Oct; 91(4):833-843. PubMed ID: 25048375 [TBL] [Abstract][Full Text] [Related]
8. Changing Antimalarial Drug Sensitivities in Uganda. Rasmussen SA; Ceja FG; Conrad MD; Tumwebaze PK; Byaruhanga O; Katairo T; Nsobya SL; Rosenthal PJ; Cooper RA Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923866 [TBL] [Abstract][Full Text] [Related]
9. Molecular monitoring of Plasmodium falciparum drug susceptibility at the time of the introduction of artemisinin-based combination therapy in Yaoundé, Cameroon: implications for the future. Menard S; Morlais I; Tahar R; Sayang C; Mayengue PI; Iriart X; Benoit-Vical F; Lemen B; Magnaval JF; Awono-Ambene P; Basco LK; Berry A Malar J; 2012 Apr; 11():113. PubMed ID: 22498364 [TBL] [Abstract][Full Text] [Related]
10. Prevalence of Plasmodium falciparum anti-malarial resistance-associated polymorphisms in pfcrt, pfmdr1 and pfnhe1 in Muheza, Tanzania, prior to introduction of artemisinin combination therapy. Gadalla NB; Tavera G; Mu J; Kabyemela ER; Fried M; Duffy PE; Sá JM; Wellems TE Malar J; 2015 Mar; 14():129. PubMed ID: 25890383 [TBL] [Abstract][Full Text] [Related]
11. Mechanistic basis for multidrug resistance and collateral drug sensitivity conferred to the malaria parasite by polymorphisms in PfMDR1 and PfCRT. Shafik SH; Richards SN; Corry B; Martin RE PLoS Biol; 2022 May; 20(5):e3001616. PubMed ID: 35507548 [TBL] [Abstract][Full Text] [Related]
12. Decreased prevalence of the Plasmodium falciparum Pfcrt K76T and Pfmdr1 and N86Y mutations post-chloroquine treatment withdrawal in Katete District, Eastern Zambia. Mulenga MC; Sitali L; Ciubotariu II; Hawela MB; Hamainza B; Chipeta J; Mharakurwa S Malar J; 2021 Jul; 20(1):329. PubMed ID: 34320992 [TBL] [Abstract][Full Text] [Related]
13. Clinical isolates of uncomplicated falciparum malaria from high and low malaria transmission areas show distinct pfcrt and pfmdr1 polymorphisms in western Ethiopia. Tadele G; Jawara A; Oboh M; Oriero E; Dugassa S; Amambua-Ngwa A; Golassa L Malar J; 2023 Jun; 22(1):171. PubMed ID: 37270589 [TBL] [Abstract][Full Text] [Related]
14. Plasmodium falciparum isolates from Angola show the StctVMNT haplotype in the pfcrt gene. Gama BE; Pereira-Carvalho GA; Lutucuta Kosi FJ; Almeida de Oliveira NK; Fortes F; Rosenthal PJ; Daniel-Ribeiro CT; de Fátima Ferreira-da-Cruz M Malar J; 2010 Jun; 9():174. PubMed ID: 20565881 [TBL] [Abstract][Full Text] [Related]
15. Discordant temporal evolution of Pfcrt and Pfmdr1 genotypes and Plasmodium falciparum in vitro drug susceptibility to 4-aminoquinolines after drug policy change in French Guiana. Legrand E; Yrinesi J; Ekala MT; Péneau J; Volney B; Berger F; Bouchier C; Bertani S; Musset L; Meynard JB; Mercereau-Puijalon O Antimicrob Agents Chemother; 2012 Mar; 56(3):1382-9. PubMed ID: 22232280 [TBL] [Abstract][Full Text] [Related]
16. Increased sensitivity of malaria parasites to common antimalaria drugs after the introduction of artemether-lumefantrine: Implication of policy change and implementation of more effective drugs in fight against malaria. Okore W; Ouma C; Okoth RO; Yeda R; Ingasia LO; Mwakio EW; Ochora DO; Wakoli DM; Amwoma JG; Chemwor GC; Juma JA; Okudo CO; Cheruiyot AC; Opot BH; Juma D; Egbo TE; Andagalu B; Roth A; Kamau E; Akala HM PLoS One; 2024; 19(6):e0298585. PubMed ID: 38900782 [TBL] [Abstract][Full Text] [Related]
17. Selection of known Plasmodium falciparum resistance-mediating polymorphisms by artemether-lumefantrine and amodiaquine-sulfadoxine-pyrimethamine but not dihydroartemisinin-piperaquine in Burkina Faso. Somé AF; Séré YY; Dokomajilar C; Zongo I; Rouamba N; Greenhouse B; Ouédraogo JB; Rosenthal PJ Antimicrob Agents Chemother; 2010 May; 54(5):1949-54. PubMed ID: 20231394 [TBL] [Abstract][Full Text] [Related]
18. Analysis of anti-malarial resistance markers in pfmdr1 and pfcrt across Southeast Asia in the Tracking Resistance to Artemisinin Collaboration. Srimuang K; Miotto O; Lim P; Fairhurst RM; Kwiatkowski DP; Woodrow CJ; Imwong M; Malar J; 2016 Nov; 15(1):541. PubMed ID: 27825353 [TBL] [Abstract][Full Text] [Related]
19. Single nucleotide polymorphisms in Plasmodium falciparum V type H(+) pyrophosphatase gene (pfvp2) and their associations with pfcrt and pfmdr1 polymorphisms. Jovel IT; Ferreira PE; Veiga MI; Malmberg M; Mårtensson A; Kaneko A; Zakeri S; Murillo C; Nosten F; Björkman A; Ursing J Infect Genet Evol; 2014 Jun; 24():111-5. PubMed ID: 24657918 [TBL] [Abstract][Full Text] [Related]
20. Temporal trends in prevalence of Plasmodium falciparum molecular markers selected for by artemether-lumefantrine treatment in pre-ACT and post-ACT parasites in western Kenya. Achieng AO; Muiruri P; Ingasia LA; Opot BH; Juma DW; Yeda R; Ngalah BS; Ogutu BR; Andagalu B; Akala HM; Kamau E Int J Parasitol Drugs Drug Resist; 2015 Dec; 5(3):92-9. PubMed ID: 26236581 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]